Carcinoma, Hepatocellular: all 3,249 studies
Page 23 of 33. Open to participants first (974), then studies with results posted, then the rest; newest registration first within each.
- Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions of Primary Hepatocellular CarcinomaWithdrawnNCT03636607Not applicable
- A Study of LioCyx in Patient With Recurrent HBV-related HCC Post Liver TransplantationWithdrawnNCT03634683Phase 1/2
- Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by ElectroporationTerminatedNCT03630640Phase 2
- Computer-assisted Tumor Ablation for Patients With Liver CancerCompletedNCT03630068
- Blood Sample Collection to Evaluate Biomarkers for Hepatocellular CarcinomaCompletedNCT03628651
- Clinical Trial of Radiotherapy in Treating Primary Hepatocellular CarcinomaStatus unknownNCT03614546Not applicable
- Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular CarcinomaStatus unknownNCT03609268Not applicable
- Stereotactic Body Radiotherapy and Surgery for Early-stage Hepatocellular CarcinomaStatus unknownNCT03609151Not applicable
- Adagloxad Simolenin/OBI-821 in Combination With TACE Therapy in HCC Patients With GALNT14-rs9679162-non-TT GenotypeTerminatedNCT03608878Phase 2
- Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant with Sorafenib for Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA)CompletedNCT03606590Phase 2
- A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Have Never Received Prior Systemic Treatment.Status unknownNCT03605706Phase 3
- Immune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral DrugsCompletedNCT03602703
- A Worldwide Score for Hepatocellular Cancer and Liver TransplantationCompletedNCT03595345
- Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection SurgeryStatus unknownNCT03594929Not applicable
- Effects of Anesthetic Methods on Hepatic Cancer Cell MalignancyCompletedNCT03594188Not applicable
- Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct TherapyStatus unknownNCT03592706Phase 2/3
- Dual TORC1/TORC2 Inhibitor ATG-008 (CC-223) in HBV Positive Advanced Hepatocellular Carcinoma (HCC) SubjectsTerminatedNCT03591965Phase 2
- TACE-HAIC vs. HAIC for Potentially Resectable HCCStatus unknownNCT03591705Not applicable
- Prospective Surveillance for Very Early Hepatocellular CarcinomaStatus unknownNCT03588442
- CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular CarcinomaTerminatedNCT03582618Phase 2
- SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCCCompletedNCT03578874Phase 2
- Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular CarcinomaCompletedNCT03572582Phase 2
- Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular CarcinomaCompletedNCT03564405Not applicable
- QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) VaccineWithdrawnNCT03563170Phase 1/2
- Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 TrialStatus unknownNCT03551444Phase 3
- Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular CarcinomaCompletedNCT03535259Phase 2
- A Comparison Between Child-Pugh and Albumin-Bilirubin ScoresCompletedNCT03534843
- Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular CarcinomaCompletedNCT03533920Not applicable
- People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral AgentsActive, not recruitingNCT03520660Phase 4
- The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor ThrombusStatus unknownNCT03520257Phase 2
- Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With MetastasisStatus unknownNCT03518502Phase 4
- Management of Spontaneous Ruptured Hepatocellular CarcinomaCompletedNCT03516890
- Expanding Phase III Study of Tyroserleutide for InjectionStatus unknownNCT03516448Phase 3
- A Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCCCompletedNCT03516071Phase 2
- Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular CarcinomaStatus unknownNCT03515369Phase 4
- Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung CancerCompletedNCT03515252Phase 1
- The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma PatientsStatus unknownNCT03511703Phase 2
- Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid TumorsTerminatedNCT03511222Phase 1
- Nivolumab Plus Ipilimumab as Neoadjuvant Therapy for Hepatocellular Carcinoma (HCC)CompletedNCT03510871Phase 2
- Efficacy and Safety of Apatinib Combined With TACE in Patients With Hepatocellular CarcinomaStatus unknownNCT03510416Phase 2
- Microbiota Study in Liver Transplanted PatientsCompletedNCT03507140
- Phase 1b of ASLAN001 (Varlitinib) in Patients With Advanced/ Metastatic Hepatocellular Carcinoma (HCC)Status unknownNCT03499626Phase 1/2
- Study on Recurrence Monitoring of Hepatocellular Carcinoma With 5-Hydroxymethylcytosine TestStatus unknownNCT03493763
- Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver TransplantationCompletedNCT03490461
- Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract CancerActive, not recruitingNCT03482102Phase 2
- R1vascular Hepatectomy for HCC PatientsCompletedNCT03476421
- Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan CriteriaStatus unknownNCT03469479Phase 3
- HAIC of FOLFOX vs. HAIC of OXA for Advanced HCCStatus unknownNCT03468231Phase 3
- Diagnostic Value of AFP-L3 and PIVKA-II in HCCCompletedNCT03460080
- Study in the Treatment of HCC With a Radiopaque (RO) Bead (LC Bead LUMI™) Loaded With DoxorubicinWithdrawnNCT03452553Not applicable
- An Open-label Phase I/II Clinical Trial of PT-112 Injection for Advanced Solid Tumors and Advanced Hepatocellular CarcinomaStatus unknownNCT03439761Phase 1/2
- Role of Choline PET/CT in Predicting Survival in Patients With Hepatocellular CarcinomaCompletedNCT03430635
- Study of microRNAs as a Diagnostic Tool for HCV-related Hepatocellular CarcinomaStatus unknownNCT03429530
- Small and Steatotic Hepatocellular CarcinomaCompletedNCT03428321
- A Study of Individualized Radiotherapy Based on a Prediction Model of Lymph Node Metastasis in Hepatocellular CarcinomaStatus unknownNCT03416803Not applicable
- The Clinical Validity and Safety of IOP Injection MRI Contrast Agent in Hepatocellular CarcinomaCompletedNCT03407495Phase 2
- Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter StudyCompletedNCT03405909
- Study of Apatinib Combined With TACE in Advance Hepatocellular CarcinomaStatus unknownNCT03398122Not applicable
- Phase II Study of Avelumab in Patients With Advanced Hepatocellular Carcinoma After Prior Sorafenib TreatmentCompletedNCT03389126Phase 2
- A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationActive, not recruitingNCT03383458Phase 3
- Nivolumab and Bevacizumab in Patients With Advanced and or Metastatic Hepatocellular CarcinomaTerminatedNCT03382886Phase 1
- Benefit of the Use of 3D Models and Tools in Hepatectomy Planning for HepatocarcinomasCompletedNCT03382327Not applicable
- A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCCCompletedNCT03380130Phase 2
- HEPAR Primary: Holmium-166-radioembolization in Hepatocellular Carcinoma PatientsCompletedNCT03379844Phase 2
- Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch TechniqueCompletedNCT03375281Not applicable
- Metabolic Signature of Healthy Lifestyle and HCCCompletedNCT03356535
- TACE for HCC by TANDEM and IdarubicinCompletedNCT03349957
- Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular CarcinomaTerminatedNCT03349255Phase 1
- Regorafenib Plus Pembrolizumab in First Line Systemic Treatment of HCCCompletedNCT03347292Phase 1
- A Clinical Study of Precision TACE (P-TACE) With SurefireWithdrawnNCT03345225Not applicable
- Evaluation of Gd-EOB-DTPA MRI for Detection and Characterization of Liver Nodules in Cirrhotic Patients Undergoing Liver Transplantation and Potential Impact on Transplant EligibilityStatus unknownNCT03342677Not applicable
- Residual Plasma Concentration of Sorafenib and Adverse Events in CHCStatus unknownNCT03340636
- SBRT or TACE for Advanced HCCStatus unknownNCT03338647Phase 3
- Role of LDH as a Predictor of Treatment Outcomes in Hepatocellular CarcinomaStatus unknownNCT03338166
- Pembrolizumab as Neoadjuvant Treatment in HCCStatus unknownNCT03337841Phase 2
- Comparison of SBRTand Repeat TACE for HCCStatus unknownNCT03326375Not applicable
- TACE Combined With Iodine-125 Seeds Implantation for HCCStatus unknownNCT03322280Not applicable
- A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCCTerminatedNCT03318562Phase 2
- The Efficacy of Hepatectomy or TILA-TACE in Patients With Resectable Hepatocellular CarcinomaStatus unknownNCT03314532Not applicable
- Multicenter RCT of ADV-TK Gene Therapy Improving the Outcome of Liver Transplantation for Advanced HCCStatus unknownNCT03313596Phase 3
- Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in CirrhosisCompletedNCT03311152Not applicable
- Endoscopic Ultrasound Guided Liver BiopsyCompletedNCT03307811Not applicable
- Hepatocellular Carcinoma in Patients With a Cirrhosis Due to an Alcoholic or a Non Alcoholic Fatty Liver DiseaseCompletedNCT03307408
- Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 RadioembolizationWithdrawnNCT03300401Not applicable
- Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients With Locally Advanced Hepatocellular Carcinoma (HCC)CompletedNCT03299946Phase 1
- Drug-loadable（T-ACE Beads）for Hepatoma Embolization TherapyCompletedNCT03299036Not applicable
- A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCCCompletedNCT03295006
- REgistry of Selective Internal Radiation Therapy in TaiwaN (RESIN)Status unknownNCT03292991
- Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC)CompletedNCT03289273
- Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular CarcinomaStatus unknownNCT03285867
- Safety and Efficacy of dRug-ElutiNg beADs Trans-arterial chemoEmbolization for Hepatocellular Carcinoma in TaiwanStatus unknownNCT03283956
- Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT03278444Phase 3
- Microwave Ablation Combined With TACE in the Treatment of Unresectable Huge Hepatocellular Carcinoma HugeStatus unknownNCT03277716Not applicable
- Statin Combination Therapy in Patients Receiving Sorafenib for Advanced Hepatocellular CarcinomaTerminatedNCT03275376Phase 2
- Treatment of Intermediate-stage Hepatocellular CarcinomaStatus unknownNCT03274427Phase 3
- Observation Study: Superselective Drug-Eluting Chemoembolization in Unresectable Intermediate and Advanced HCC PatientsStatus unknownNCT03273608
- Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular CarcinomaCompletedNCT03267641
- Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family CaregiversCompletedNCT03267524Not applicable
- Comparing Diagnostic Accuracy for Liver Tumours Between the Combination of CEUS and CEMRI Versus CECT and CEMRICompletedNCT03267290Not applicable
- Study of E7386 in Participants With Selected Advanced NeoplasmsActive, not recruitingNCT03264664Phase 1